Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer

NCT05338307 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT05338307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05338307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 13, 2022
Completion date
June 30, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer